#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA666393	F	Inhibitory concentration required to reduce viral plaque formation of Coxsackie B5 virus by 50%	Coxsackievirus B5	3	ALA1132137	organism-based format	Scientific Literature
2.	ALA664048	F	Antiviral activity against the Coxsackie B5 virus (RNA virus) at a concentration of 5 ug/mL was determined as total cell infectious dose 50/mL (TCID50) by viral yield assay	Coxsackievirus B5	2	ALA1132137	organism-based format	Scientific Literature
3.	ALA694175	F	Antiviral activity against the Herpes simplex 1 virus (DNA virus) at a concentration of 5 ug/mL was determined as Plaque forming unit/mL(PFU) by plaque assay	Human alphaherpesvirus 1	1	ALA1132137	organism-based format	Scientific Literature
4.	ALA746205	F	Antiviral activity against the Mumps virus (RNA virus) at a concentration of 5 ug/mL was determined as total cell infectious dose 50/mL (TCID50) by viral yield assay	Mumps orthorubulavirus	1	ALA1132137	organism-based format	Scientific Literature
5.	ALA817939	F	Cytotoxicity on the vero cell culture infected with Coxsackie B5 virus at a concentration of 10 ug/mL was determined as cell viability by the MTT test	Chlorocebus sabaeus	1	ALA1132137	cell-based format	Scientific Literature
6.	ALA817802	F	Cytotoxicity on the vero cell culture infected with mL and was determined as reduction in protein content by the Lowry test	Chlorocebus sabaeus	1	ALA1132137	cell-based format	Scientific Literature
7.	ALA816213	F	Cytotoxicity on the vero cell culture infected with mL and was determined as reduction in protein content by the Lowry test	Chlorocebus sabaeus	5	ALA1132137	cell-based format	Scientific Literature
8.	ALA823645	F	Antiviral activity against the Vaccinia virus (DNA virus) at a concentration of 5 ug/mL was determined as Plaque forming unit/mL(PFU) by plaque assay	Vaccinia virus	1	ALA1132137	organism-based format	Scientific Literature